Salihu Hamisu M
Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, USA.
Int J MCH AIDS. 2015;4(2):8-10.
Dr. Holtz and colleagues present a synthesis of evidence from published studies over the previous decade on the collective impact of HIV-targeted interventions on maternal mortality. Amongst an assortment of interventions [that include antiretroviral therapy (ART), micronutrients (multivitamins, vitamin A and selenium), and antibiotics], only ART reduced maternal mortality among HIV-infected pregnant and post-partum mothers. These findings have fundamental and global strategic implications. They are also timely since they provide the evidence that ART reduces HIV-related maternal mortality, and by further enhancing access to ART in HIV-challenged and poor regions of the world, significant improvement in maternal morbidity and mortality indices could be attained. The paper bears good tidings and sound scientific proof that the financial investment made globally by government and non-governmental organizations and agencies to reduce the global burden of HIV/AIDS primarily by making ART more accessible to regions of the world most affected by the epidemic is beginning to show beneficial effects not only in terms of numerical reductions in the rates of new cases of HIV/AIDS among women, but also in maternal mortality levels.
霍尔茨博士及其同事综合了过去十年已发表研究中关于针对艾滋病毒的干预措施对孕产妇死亡率的总体影响的证据。在一系列干预措施中(包括抗逆转录病毒疗法、微量营养素、多种维生素、维生素A和硒),只有抗逆转录病毒疗法降低了感染艾滋病毒的孕妇和产后母亲的孕产妇死亡率。这些发现具有根本和全球战略意义。它们也很及时,因为它们提供了证据表明抗逆转录病毒疗法降低了与艾滋病毒相关的孕产妇死亡率,并且通过在世界上受艾滋病毒影响且贫困的地区进一步扩大抗逆转录病毒疗法的可及性,可以使孕产妇发病率和死亡率指标得到显著改善。该论文带来了好消息和可靠的科学证据,表明全球政府、非政府组织和机构为减轻全球艾滋病毒/艾滋病负担而做出的财政投资,主要是通过使抗逆转录病毒疗法在世界上受该流行病影响最严重的地区更容易获得,不仅在降低女性艾滋病毒/艾滋病新病例数方面开始显示出有益效果,而且在孕产妇死亡率水平方面也是如此。